Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. (Q38625776)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

meta-analysis

0 references

title

Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

Ana-Marija Hristovska

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Patricia Duch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Mikkel Allingstrup

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Arash Afshari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

publication date

14 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

27 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

page(s)

CD012763

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

Intraoperative reversal of neuromuscular block with sugammadex or neostigmine during extreme lateral interbody fusion, a novel technique for spine surgery.

27 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex allows fast-track bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex reduces postoperative pain after laparoscopic bariatric surgery: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Comparison of sugammadex and neostigmine-atropine on intraocular pressure and postoperative effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Comparison of sugammadex and conventional reversal on postoperative nausea and vomiting: a randomized, blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Effect of Sugammadex on Postoperative Bleeding and Coagulation Parameters After Septoplasty: A Randomized Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Elevated BIS and Entropy values after sugammadex or neostigmine: an electroencephalographic or electromyographic phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Stimulus frequency in the detection of neuromuscular block in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Quantitative assessment of residual antidepolarizing block. II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Interaction revisited: the difference between two estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Atracurium associated with postoperative residual curarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Impact of anesthesia management characteristics on severe morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Postoperative residual neuromuscular block: a survey of management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Residual block after mivacurium with or without edrophonium reversal in adults and children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Assessment of residual curarization using low-current stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Clinical limitations of acetylcholinesterase antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Residual Paralysis in the PACU after a Single Intubating Dose of Nondepolarizing Muscle Relaxant with an Intermediate Duration of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Postoperative upper airway obstruction after recovery of the train of four ratio of the adductor pollicis muscle from neuromuscular blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Recovery from neuromuscular blockade: residual curarisation following atracurium or vecuronium by bolus dosing or infusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Is sugammadex economically viable for routine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Postoperative residual block after intermediate-acting neuromuscular blocking drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Estimating the mean and variance from the median, range, and the size of a sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

The Accelograph: a new neuromuscular transmission monitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex: A Review of Neuromuscular Blockade Reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Discrete sequential boundaries for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Atracurium is associated with postoperative residual curarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Antagonism of the muscarinic effects of edrophonium with atropine or glycopyrrolate. A comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Postoperative residual neuromuscular blockade is associated with impaired clinical recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Benefits and risks of sugammadex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Residual paralysis after emergence from anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Overcoming the limitations of current meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

The Mini-Mental State Examination: A Comprehensive Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Measurement of acceleration: a new method of monitoring neuromuscular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Postoperative residual curarization and evidence-based anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Estimating required information size by quantifying diversity in random-effects model meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012763

Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs.

21 January 2018

1 reference

12 December 2020

Residual Curarization in the Recovery Room

1 reference

12 December 2020

Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response

1 reference

12 December 2020

Postoperative residual curarisation: incidence, aetiology and associated morbidity

1 reference

12 December 2020

Complications and death following anaesthesia. A prospective study with special reference to the influence of patient-, anaesthesia-, and surgery-related risk factors

1 reference

12 December 2020

1 reference

12 December 2020

Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial

1 reference

12 December 2020

Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade.

1 reference

12 December 2020

1 reference

12 December 2020

Decreases in anesthesia-controlled time cannot permit one additional surgical operation to be reliably scheduled during the workday.

1 reference

12 December 2020

Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium.

1 reference

12 December 2020

Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period

1 reference

12 December 2020

Sugammadex: a novel selective relaxant binding agent

1 reference

12 December 2020

[Clinical evaluation of post-surgical bleeding after a sugammadex injection]

1 reference

12 December 2020

Comparison of neostigmine and sugammadex for hemodynamic parameters in cardiac patients undergoing noncardiac surgery

1 reference

12 December 2020

[Sugammadex versus neostigmine in pediatric patients: a prospective randomized study]

1 reference

12 December 2020

Comparison of reversal and adverse effects of sugammadex and combination of - Anticholinergic-Anticholinesterase agents in pediatric patients

1 reference

12 December 2020

Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade.

1 reference

12 December 2020

The clock-drawing test. 1998

1 reference

12 December 2020

Effects of Sugammadex and Neostigmine on Renal Biomarkers.

1 reference

12 December 2020

Intraocular pressure changes associated with tracheal extubation: Comparison of sugammadex with conventional reversal of neuromuscular blockade.

1 reference

12 December 2020

Reversal of neuromuscular blockade with sugammadex or neostigmine/atropine: Effect on postoperative gastrointestinal motility

1 reference

12 December 2020

Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses

1 reference

12 December 2020

10.1002/14651858.CD012763

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

release_xjirtw2kcvdgtin2efd55zz4ai

27 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xjirtw2kcvdgtin2efd55zz4ai

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28806470%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference